Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Metformin and Alveolar Cleft [Phase 2]

View source ↗

Summary

A Phase 2 trial investigates metformin for alveolar cleft. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Fayoum University | Conditions: Alveolar Cleft | Phase 2 | Status: NOT_YET_RECRUITING